SMTL ID : 7n81.1

Crystal Structure of PI5P4KIIBeta complex with CC260

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

homo-dimer

Ligands

1 x HKP: (7R)-8-cyclopentyl-7-(cyclopentylmethyl)-2-[(3,5-dichloro-4-hydroxyphenyl)amino]-5-methyl-7,8-dihydropteridin-6(5H)-one(Non-covalent)

HKP.1: 17 residues within 4Å: Chain B: S.105, D.106, S.107, Q.108, F.115, V.124, K.126, P.157, F.159, V.175, R.178, N.179, V.180, F.181, K.190, I.344, L.347 15 PLIP interactions: 15 interactions with chain B Hydrophobic interactions: B:F.115, B:F.115, B:K.126, B:F.159, B:V.175, B:F.181, B:I.344, B:L.347 Hydrogen bonds: B:S.107, B:N.179, B:V.180, B:K.190, B:K.190 Water bridges: B:D.345 pi-Stacking: B:F.115

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chen, S. et al., Pharmacological inhibition of PI5P4K alpha / beta disrupts cell energy metabolism and selectively kills p53-null tumor cells. Proc.Natl.Acad.Sci.USA (2021)

Release Date

2021-06-30

Peptides

Phosphatidylinositol 5-phosphate 4-kinase type-2 beta: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Phosphatidylinositol 5-phosphate 4-kinase type-2 beta

Related Entries With Identical Sequence